Viewing Study NCT00812266


Ignite Creation Date: 2025-12-24 @ 4:41 PM
Ignite Modification Date: 2026-05-21 @ 9:02 AM
Study NCT ID: NCT00812266
Status: TERMINATED
Last Update Posted: 2016-01-26
First Post: 2008-12-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED)
Sponsor: Danish Oncological Lung Cancer Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extensive Disease View
None First-Line View
None Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SCLC View
None Extensive disease View
None topotecan View